First in New Class of Drugs in More than a Decade for SLE and Targeting Type 1 Interferons NEW YORK, Aug. 2, 2021 /PRNewswire/ -- The Lupus Research Alliance (LRA) is particularly excited about the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback